Shotlee LogoShotlee

What Is GHK-Cu?

GHK-Cu is the copper chelate of the tripeptide Glycine-Histidine-Lysine. It was first isolated from human plasma by researcher Loren Pickart in 1973, who noticed that older liver cells could be rejuvenated by young human plasma — and traced the active component to this small tripeptide-copper complex. GHK-Cu is naturally present in human plasma, urine, and saliva, playing a role in tissue repair signaling throughout life.

The compound's blood plasma concentration is not stable across the lifespan. In young adults (approximately 20s), plasma GHK-Cu runs around 200ng/mL. By the 60s, this drops to roughly 80ng/mL — a 60% decline. This age-related decline tracks closely with the loss of tissue repair capacity, collagen density, skin elasticity, and immune resilience that characterizes biological aging. Whether the decline causes aging or merely correlates with it remains under study, but supplementing GHK-Cu has become a major focus of anti-aging research.

The copper ion (Cu2+) is integral to GHK-Cu's function — it is not simply a carrier molecule. Copper is a cofactor for lysyl oxidase (the enzyme that crosslinks collagen and elastin), superoxide dismutase (SOD, an antioxidant enzyme), and ceruloplasmin. By delivering bioavailable copper directly to cells, GHK-Cu enables a suite of enzymatic processes that support structural protein synthesis and oxidative defense.

4,000+
Genes Modulated

GHK-Cu modulates over 4,000 human genes — one of the broadest regulatory footprints of any known peptide compound.

60%
Age Gene Reversal

Pickart and Margolina (2018): GHK-Cu reverses approximately 60% of age-related gene expression changes in human cell models.

1973
Discovery Year

One of the longest-studied anti-aging peptides — over 50 years of research, more cosmetic data than any comparable compound.

How GHK-Cu Works: Mechanisms

Collagen & Elastin Synthesis

GHK-Cu upregulates collagen synthesis in fibroblasts — specifically types I, III, and IV. It also promotes elastin production and glycosaminoglycans (including hyaluronic acid), which together form the structural matrix of healthy skin. The copper ion delivered by GHK-Cu is a required cofactor for lysyl oxidase, the enzyme that crosslinks newly synthesized collagen fibers into functional structural protein. Without lysyl oxidase activity, collagen is produced but remains unorganized and mechanically weak.

Antioxidant Enzyme Induction

GHK-Cu upregulates two of the most important endogenous antioxidant enzymes: superoxide dismutase (SOD) and catalase. SOD converts the superoxide radical (O2−) to hydrogen peroxide; catalase then converts hydrogen peroxide to water. Together they neutralize reactive oxygen species that drive cellular aging, UV damage, and chronic inflammation. This antioxidant induction is particularly relevant in skin, where UV exposure continuously generates oxidative stress throughout life.

Anti-Inflammatory Gene Regulation

GHK-Cu suppresses TNF-α (tumor necrosis factor alpha) — one of the master regulators of systemic inflammation — and downregulates NF-kB signaling, the transcription factor responsible for inflammatory gene cascades. This anti-inflammatory action at the transcriptional level is one reason GHK-Cu shows utility not just for skin but for chronic inflammatory conditions. Unlike corticosteroids, it achieves anti-inflammatory effects without impairing healing or causing tissue atrophy.

DNA Repair & Stem Cell Activation

GHK-Cu activates DNA repair systems — upregulating genes in nucleotide excision repair and base excision repair pathways that fix UV-induced and oxidative DNA damage. It also promotes stem cell activation in multiple tissue types: skin stem cells (keratinocytes, melanocytes), hair follicle stem cells, and potentially neural stem cells. This stem cell activation underpins its wound healing effects — GHK-Cu doesn't just inhibit damage, it recruits the cell populations needed to rebuild tissue.

Routes of Administration & Dosage

Topical (Cosmetic)

The most established and best-researched route. GHK-Cu penetrates the skin barrier at concentrations above 0.1% and acts locally on fibroblasts, keratinocytes, and melanocytes.

  • • Concentration: 0.1–2% in serum/cream
  • • Application: Once or twice daily to face/scalp
  • • Best for: Wrinkles, skin tightening, UV damage reversal, hair serums
  • • Onset: Gradual over 4–12 weeks

Subcutaneous Injection

For systemic anti-aging effects beyond what topical can achieve — full-body gene expression modulation, hair follicle activation from inside, and systemic antioxidant upregulation.

  • • Dose: 1–2mg/day or every other day
  • • Route: SQ abdominal or scalp (for hair)
  • • Cycle: 4–8 weeks on, 4 weeks off
  • • Best for: Systemic anti-aging, hair loss, wound healing

Intranasal

Early-stage research route exploring CNS delivery via the nasal-brain pathway. GHK-Cu's gene expression effects on neuronal cells are documented in vitro — intranasal may allow direct CNS delivery without systemic distribution.

  • • Dose: Not yet established
  • • Status: Exploratory / research only
  • • Potential: BDNF upregulation, neuroprotection
  • • Note: Very limited human data exists

GHK-Cu Effects by Application

Skin & Anti-Aging

  • Wrinkle reduction: Multiple controlled studies demonstrate significant wrinkle depth reduction with topical GHK-Cu over 12 weeks — comparable to retinoic acid results in some trials without the irritation profile.
  • Skin tightening: Increases skin density and thickness by stimulating collagen and elastin — measurable improvements in firmness via ultrasonographic skin analysis.
  • UV damage reversal: Activates DNA repair pathways that fix UV-induced photodamage; reduces solar lentigines (age spots) through melanin regulation.
  • Wound healing: Accelerates wound closure rates comparable to vitamin A in some studies. Promotes keratinocyte migration and proliferation, reduces wound inflammation.

Hair Restoration

  • Follicle enlargement: GHK-Cu stimulates hair follicle cell proliferation and increases follicle size — larger follicles produce thicker, stronger hair shafts. This is the key metric in clinical hair loss research.
  • Anagen phase prolongation: Extends the active growth phase of the hair cycle — more time in anagen means longer, denser hair before the resting (telogen) phase begins.
  • Topical application: Hair loss serums containing 0.5–2% GHK-Cu are widely used as adjuncts to minoxidil or standalone treatments for diffuse hair thinning.
  • Scalp injection: Subcutaneous scalp injection delivers GHK-Cu directly to follicle-rich tissue — used in mesotherapy protocols for androgenetic alopecia.

Systemic Anti-Aging

  • Gene expression reversal: Pickart/Margolina (2018) — GHK-Cu reversed approximately 60% of age-related gene expression changes in human cell models. Activated genes include collagen, antioxidant enzymes, DNA repair, and stem cell markers; suppressed genes include inflammatory cytokines and oxidative stress markers.
  • Systemic antioxidant upregulation: Via injectable routes, GHK-Cu raises SOD and catalase systemically — relevant to reducing oxidative burden in liver, kidney, and cardiovascular tissue.
  • Longevity stacking: Often combined with other longevity peptides in multi-compound protocols. Pairs well with BPC-157 (acute healing) and Epithalon (telomere extension) in comprehensive anti-aging regimens.

Wound & Tissue Repair

  • Acute wound healing: Clinical studies in wound care show accelerated closure rates with topical GHK-Cu. FDA-cleared wound dressings incorporating copper peptides exist in the medical device space.
  • Bone and connective tissue: Promotes osteoblast activity and may support bone remodeling — studied in osteoporosis models.
  • Diabetic wounds: Of particular interest in diabetic wound care — impaired copper metabolism in diabetes may contribute to delayed healing, and topical GHK-Cu helps restore it.

Why GHK-Cu Outperforms Retinol for Many Users

Retinoic acid (the active form of vitamin A) is the gold standard active ingredient in anti-aging dermatology, with decades of double-blind RCT data showing wrinkle reduction, skin thickening, and photoaging reversal. GHK-Cu performs comparably in some measures — but through a completely different mechanism and without retinoid side effects.

Retinol/Retinoic Acid

  • • Well-documented wrinkle reduction
  • • Skin peeling and irritation (purge phase)
  • • Photosensitivity — avoid sun exposure
  • • Teratogenic — contraindicated in pregnancy
  • • Receptor-mediated nuclear signaling

GHK-Cu

  • • Comparable collagen and wrinkle results
  • • No irritation or purge phase
  • • No photosensitivity — can use AM/PM
  • • No known teratogenicity
  • • Gene expression modulation via copper-mediated signaling

Frequently Asked Questions

What is GHK-Cu and how does it work?

GHK-Cu is a copper tripeptide complex (Glycine-Histidine-Lysine chelated to Cu2+) naturally present in human plasma, urine, and saliva. First isolated by Loren Pickart in 1973, it enters cells, binds copper, and modulates over 4,000 human genes — activating tissue repair, antioxidant defense, collagen synthesis, and stem cell pathways while suppressing inflammatory and oxidative stress gene programs. Its plasma concentration declines 60% between young adulthood and old age, making supplementation a target in anti-aging protocols.

What is the best route of administration for GHK-Cu?

For skin rejuvenation, topical application at 0.1–2% concentration is the most established and evidence-backed route — with decades of cosmetic clinical data. For hair loss, topical scalp serums or subcutaneous scalp injection are used. For systemic anti-aging effects — including systemic antioxidant upregulation and full-body gene expression modulation — subcutaneous injection at 1–2mg per day or every other day is the primary approach. Intranasal delivery is being explored for cognitive and neuroprotective applications but has very limited human data.

Can GHK-Cu reverse aging at the gene level?

Research by Pickart and Margolina (2018) showed that GHK-Cu reverses approximately 60% of age-related gene expression changes in human cell models, activating genes associated with collagen synthesis, DNA repair, antioxidant enzyme production, and stem cell activity while suppressing pro-inflammatory and oxidative stress gene programs. While this is cell culture data rather than in-vivo human trial data, the breadth and consistency of the effect is among the most compelling in the entire field of peptide anti-aging research.

Track Your GHK-Cu Protocol with Shotlee

Log topical applications, injections, and biomarker changes in one place. Build your personal anti-aging dataset over time.

Start Tracking Free